Skip to main content
Livermore
Livermore
ZHEN

Glen Eagle Advisors, LLC

SEC CIK
0002029317
Latest filing
Aug 14, 2026

AZN holding history

AstraZeneca PLC in every 13F filed by Glen Eagle Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AZN overviewAll 13F holders of AZNFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of AZN by Glen Eagle Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−140−100.0%Sold outConverted for a 1-for-2 splitHolders
Q4 2025279$25.6K<0.1%−11−3.8%ReducedHolders
Q3 2025290$22.2K<0.1%−150−34.1%ReducedHolders
Q2 2025440$30.7K<0.1%00.0%UnchangedHolders
Q1 2025440$32.3K<0.1%−141−24.3%ReducedHolders
Q4 2024581$38.1K<0.1%00.0%UnchangedHolders
Q3 2024581$45.3K<0.1%+7+1.2%AddedHolders
Q2 2024574$44.8K<0.1%+307+115.0%AddedHolders
Q1 2024267$18.1K<0.1%00.0%UnchangedHolders
Q4 2023267$18.0K<0.1%−50−15.8%ReducedHolders
Q3 2023317$21.5K<0.1%+21+7.1%AddedHolders
Q2 2023296$21.1K<0.1%+1+0.3%AddedHolders
Q1 2023295$20.5K<0.1%−12−3.9%ReducedHolders
Q4 2022307$20.8K<0.1%+177+136.2%AddedHolders
Q3 2022130$7.13K<0.1%+47+56.6%AddedHolders
Q2 202283$5.48K<0.1%−15−15.3%ReducedHolders
Q1 202298$6.50K<0.1%00.0%UnchangedHolders
Q4 202198$5.71K<0.1%−455−82.3%ReducedHolders
Q3 2021553$33.2K<0.1%00.0%UnchangedHolders
Q2 2021553$33.1K<0.1%00.0%UnchangedHolders
Q1 2021553$27.5K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.